H1 2026 Financial Highlights:

• The Group's revenues for the first half of 2026 reached CZK 15.9 billion, up 44.2% y-o-y, driven by organic growth in traditional segments serving M&LE customers, and by the consolidation of revenues from the energetics segment following the acquisition of Synthesia Nitrocellulose and Synthesia Power.

• Adjusted EBITDA in the first half of 2026 amounted to CZK 4.6 billion, which is up by 95.1% y-o-y compared with the adjusted EBITDA for the first six months in 2025, due to higher margins, particularly in the ammunition and energetics segments.

• Net profit for six months ended June 30, 2026, increased by 72.7% to CZK 1.6 billion, compared to the same period in 2025, driven by stronger operating profitability and the consolidation of the energetics segment as of January 1, 2026.

“We delivered very strong results in the first half of 2026, validating our long-term strategy of building a vertically integrated and geographically diversified Group, while also demonstrating the significant progress we are making in enhancing our competitiveness. All our segments performed well – we delivered very good results in the firearms segment, significantly improved profitability in the ammunition segment, and our new energetics segment also made a substantial contribution. We enter the second half of the year with a high level of expected revenues already covered by confirmed orders and are therefore raising our full-year revenue and adjusted EBITDA guidance,” said Radek Musil, CEO of Colt CZ Group.

Revenues by Segments

Revenues from the firearms segment increased by 37.4% y-o-y in the first half of 2026, to a total of CZK 8.0 billion. The number of firearms sold rose slightly by 0.6% to 291,724 units, primarily due to a favorable sales mix, new M&LE contracts, and the growing performance of Colt Canada and Colt. Sales of long firearms increased by 10.0% y-o-y to 126,276 units, while sales of short guns recorded a slight decrease of 5.5% to 165,448 units due to changes in the sales mix.

Revenues from the ammunition segment slightly declined by 5.0% y-o-y in the first half of 2026 and amounted to CZK 4.9 billion due to a decrease in sales under the Czech ammunition initiative. Despite a decline in revenues, the ammunition segment is highly profitable, with an adjusted EBITDA margin of 33.2%, compared with a margin of 26.5% in the first half of 2025.

Revenues in the energetics segment reached CZK 3.0 billion, up 14.3% compared to the same period in 2025 (on a proforma basis). As expected, the energetics segment reported strong profitability. Adjusted EBITDA amounted to CZK 1.6 billion, with an adjusted EBITDA margin of 54.5% in the first half of 2026.

Revenues by Regions

Revenues from sales in the Czech Republic in the first half of 2026 expanded y-o-y by 94.6% to CZK 2.7 billion, mainly due to the consolidation of the new energetics segment as of January 1, 2026.

Revenues generated in Europe (excluding the Czech Republic) went up y-o-y by 52.8% to CZK 6.0 billion, mainly driven by the consolidation of the new energetics segment.

Revenues from sales in the United States decreased y-o-y by 12.7%, to CZK 3.5 billion, mainly due to the seasonality of M&LE contracts, as well as a decline in ammunition segment revenues resulting from the imposition of U.S. tariffs and the subsequent shift of part of deliveries to European markets. At the same time, there was a slight recovery in the commercial market, where the Colt brand performed particularly well.

Revenues generated in Canada for the first half of 2026 totaled CZK 1.9 billion, an increase of 271% y-o-y, thanks to a new contract to supply rifles to the Canadian Army and an increase in rifle deliveries to the Danish Ministry of Defense.

Revenues generated in Africa fell by 8.6% to CZK 120.9 million, due to the seasonality of supplies.

Revenues generated in Asia rose by 87.3% y-o-y, reaching CZK 1.2 billion. This growth was driven primarily by increased shipments from Colt, which had been postponed to 2025 due to the U.S. government shutdown.

In the Latin America region, sales for the first six months of 2026 amounted to CZK 281.7 million, amounting to 2.7% more
y-o-y. Sales to other regions reached CZK 46.1 million, down 16.4% y-o-y.

Closing of Synthesia Nitrocellulose Acquisition

Based on the SPA from August 2025, Colt CZ acquired on January 6, 2026, a 51% stake in Synthesia Nitrocellulose, a.s. and Synthesia Power, a.s. The remaining 49% of both companies may be acquired under the agreed put and call option terms within a period starting two years after the completion of the acquisition of the 51% stake.

Synthesia Nitrocellulose, a.s. is one of the largest energetic nitrocellulose manufacturers in Europe and North America. Energetic nitrocellulose is a basic raw material to produce single and multi-component powders and propellants, and is essential for the production of small-, medium-, and large-caliber ammunition. Synthesia Nitrocellulose is also a major manufacturer of industrial nitrocellulose and oxycellulose for healthcare use. By integrating Synthesia Nitrocellulose, the Group is strengthening its control over a key raw material for ammunition production, increasing the resilience of its supply chain, and at the same time creating opportunities for further technological and product development in the medium- and large-caliber ammunition segment.

Dual Listing on Euronext Amsterdam 

On April 13, 2026, the Company announced the admission of its ordinary shares to trading on the regulated market of Euronext Amsterdam, operated by Euronext Amsterdam N.V. The dual listing on Euronext Amsterdam complements the existing trading of Colt CZ shares on the Prime Market of the Prague Stock Exchange, where the Company has been listed since June 1, 2020.

Trading in Colt CZ shares on Euronext Amsterdam commenced on April 15 at 9:00 a.m. CEST under the ticker symbol “COLT”. The shares are fully fungible between Euronext Amsterdam and the Prague Stock Exchange.

Depending on market conditions, the Company may pursue a capital increase while retaining full flexibility regarding timing, including the possibility of postponing the transaction to a later date. The net proceeds from the planned capital increase may be used for further strategic investments, acquisitions, and development including: i) strategic investments in continued technological modernization and production capacity increases, ii) strengthening innovation capacity and research and development, iii) personnel and organizational strengthening, iv) targeted and disciplined acquisition of manufacturers of products complementary to Colt CZ Group's product portfolio, as well as v) partial reduction of the Company's existing debt.

Selected New M&LE Contracts

In March, Colt Canada received a significant contract from the Canadian government under the Canadian Modular Assault Rifle Project (CMAR) to modernize the C7/C8 rifles, which have been in service with the Canadian Armed Forces for more than 35 years. As part of the contract, Colt Canada is to supply 30,000 assault rifles between 2026 and 2029, with provisions for additional quantities. Colt Canada also continues to fulfill its contract with the Danish Ministry of Defense.

In the first half of 2026, Colt secured a new contract, awarded through the U.S. government, for M4 rifles intended for foreign customers under the Foreign Military Sales (FMS) program. Sellier & Bellot also gained new orders, strengthening its position in several European countries, including Spain, Poland, Romania, Croatia, and Estonia, as well as through NSPA (NATO Support and Procurement Agency).

Outlook for the Second Half of 2026

For the remainder of 2026, the Group will continue to pursue significant contracts in the military and law enforcement segment, particularly in NATO and EU member states and in cooperation with the NSPA. At the same time, the Group continues to strengthen its position in other markets, particularly in Asia. The key factors for achieving the outlook will be success in new tenders, the timely execution of contracts, and the pace of recovery in the U.S. commercial market, where the Company is focused on mitigating the impact of weaker demand and import tariffs through cost control and the launch of new products.

Consistent with its previous communications, Colt CZ continues to view the new energetics segment as a key growth driver for 2026. Thanks to its high profitability, the Company expects this segment to account for approximately 16% of the Group’s total revenues and around one-third of adjusted EBITDA. 

In light of the above, the Group is raising its guidance for 2026 and now expects revenues of CZK 31.0–33.0 billion and adjusted EBITDA of CZK 8.0–8.5 billion. The increased guidance is supported by the high level of expected revenues through already confirmed orders in the M&LE segment.

About Colt CZ Group SE

Colt CZ Group (Colt CZ) is one of the world's leading vertically integrated manufacturers of firearms, ammunition, and energetics, serving military and law enforcement as well as commercial markets. The Group markets and sells its products mainly under the Colt, CZ (Česká zbrojovka), Colt Canada, Colt Optics, Dan Wesson, Sellier & Bellot, Spuhr, swissAA, and 4M Tactical brands. The Group is also active in the production of energetic nitrocellulose through Synthesia Nitrocellulose. 

Colt CZ Group is headquartered in the Czech Republic and employs more than 4,500 people across 13 production facilities in the Czech Republic, the United States, Canada, Sweden, Switzerland, and Hungary. The Group has been listed on the Prague Stock Exchange since 2020 and completed its dual listing on Euronext Amsterdam in April 2026. Its largest shareholder is Česká zbrojovka Partners SE.